Conceptio
›
acute-myeloid-leukemia
Topic
acute-myeloid-leukemia
Knowledge-graph topic
· documents ABOUT acute-myeloid-leukemia across the archive
438
Documents about acute-myeloid-leukemia
Documents about acute-myeloid-leukemia
Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy
#869824
ClinicalTrials.gov
Study of Tipifarnib as Postconsolidation Therapy for Acute Myeloid Leukemia in Patients 60 Years and Older
#870578
ClinicalTrials.gov
Evaluation of Measurable Residual Disease in Patients With Acute Myeloid Leukemia as Surrogate Endpoint for Survival
#870935
ClinicalTrials.gov
Effectiveness of Medium-Dose Cytarabine Combined With Venetoclax for Consolidation Therapy in Elderly Patients With Intermediate to High-Risk Acute Myeloid Leukemia
#873964
ClinicalTrials.gov
Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients
#881557
ClinicalTrials.gov
A Clinical Study to Explore the Safety and Efficacy of CD33 CAR-T Cell in Relapsed/Refractory Acute Myeloid Leukemia
#882885
ClinicalTrials.gov
TAA05 Injection in the Treatment of Adult Patients With FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia
#909842
ClinicalTrials.gov
RWE of 1st Line Treatment in Adults With AML From 18 to 70 Years Old.
#910351
ClinicalTrials.gov
A Phase II Study of Selinexor Plus Cytarabine and Idarubicin in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)
#1033537
ClinicalTrials.gov
Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm
#1030242
ClinicalTrials.gov
Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies
#1031992
ClinicalTrials.gov
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
#903424
ClinicalTrials.gov
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
#67875
ClinicalTrials.gov
Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia
#848321
ClinicalTrials.gov
Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes
#895686
ClinicalTrials.gov
Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
#18710
ClinicalTrials.gov
Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia
#835574
ClinicalTrials.gov
HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies
#387146
ClinicalTrials.gov
Azacitidine in Haploidentical Donor Hematopoietic Cell Transplantation
#981393
ClinicalTrials.gov
Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy
#1007379
ClinicalTrials.gov
Study Evaluating the Efficacy and Safety of the Addition of Ivosidenib to Oral Azacitidine (Onureg®) in Patients Over 55 With Acute Myeloid Leukemia (AML) and IDH1 Mutation, in Complete Remission After Intensive Chemotherapy.
#968061
ClinicalTrials.gov
Efficacy and Safety of Immunotherapy With Allogeneic Dendritic Cells, DCP-001, in Patients With Acute Myeloid Leukaemia
#321683
ClinicalTrials.gov
Intermittent Liposomal Amphotericin B Primary Prophylaxis
#969250
ClinicalTrials.gov
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
#1008230
ClinicalTrials.gov
AflacLL1901 (CHOA-AML)
#828143
ClinicalTrials.gov
Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
#844967
ClinicalTrials.gov
Transcription factor 12 promotes acute myeloid leukemia cell survival by regulating mitochondrial function and ROS.
#686619
PubMed
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
#856671
ClinicalTrials.gov
Pilot Study of Feasibility of Outpatient Daily High Dose Cytarabine as Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML)
#859353
ClinicalTrials.gov
CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
#862869
ClinicalTrials.gov
Observational Study on the Outcome of AML Patients Treated With New Drugs in Real-life (BoxTrial)
#863781
ClinicalTrials.gov
APR-246 in Combination With Azacitidine for TP53 Mutated AML (Acute Myeloid Leukemia) or MDS (Myelodysplastic Syndromes) Following Allogeneic Stem Cell Transplant
#872384
ClinicalTrials.gov
Study of AZD5991 Alone or in Combination With Venetoclax in Relapsed or Refractory Haematologic Malignancies.
#877509
ClinicalTrials.gov
Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome
#881980
ClinicalTrials.gov
A Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid Leukemia
#911836
ClinicalTrials.gov
LBH589 Plus Decitabine for Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)
#980572
ClinicalTrials.gov
Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Re-treatment for Patients With High-Risk Acute Myeloid Leukemia
#1009001
ClinicalTrials.gov
A Study of APTO-253 in Patients With Relapsed or Refractory AML or MDS
#908025
ClinicalTrials.gov
PKC412 and 5-Azacytidine
#1009041
ClinicalTrials.gov
A Safety Study of SGN-CD33A in AML Patients
#1032401
ClinicalTrials.gov
Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia
#837371
ClinicalTrials.gov
Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 Blockade
#407715
ClinicalTrials.gov
Busulfan and Cyclophosphamide Followed By ALLO BMT
#842080
ClinicalTrials.gov
Predicting isocitrate dehydrogenase mutation status in acute myeloid leukemia from gene expression profiles by machine learning
#411863
HAL (France)
Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia
#802578
ClinicalTrials.gov
A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia
#807620
ClinicalTrials.gov
Maintenance Therapy of Hypomethylating Agent (HMA) in Favorable Risk Acute Myeloid Leukemia (AML) Patients
#899825
ClinicalTrials.gov
Study of SGR-2921 in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
#907384
ClinicalTrials.gov
Optimal minimal residual disease threshold in pediatric acute myeloid leukemia: A retrospective cohort study based on the TARGET database
#162581
PLOS
Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia
#893901
ClinicalTrials.gov
← Previous
Page 9 of 19
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.